Cetuximab and irinotecan as third line therapy in patients with advanced colorectal cancer after failure of irinotecan, oxaliplatin and 5-fluorouracil.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples